Logo

American Heart Association

  2
  0


Final ID:

Novel Therapies in the Management of Cardiac Amyloidosis and Access to Care

  • Falk, Rodney  ( Brigham and Women's Hospital Heart and Vascular Center , Boston , Massachusetts , United States )
  • Kittleson, Michelle  ( Cedars Sinai , Los Angeles , California , United States )
  • Cuddy, Sarah  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Rodney Falk: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Novo Nordisk: DSMB:Active (exists now) ; Consultant:Alnylam:Active (exists now) ; Other (please indicate in the box next to the company name):Alexion: DSMB:Active (exists now) | Michelle Kittleson: DO NOT have relevant financial relationships | Sarah Cuddy: DO have relevant financial relationships ; Advisor:Bridgebio:Active (exists now) ; Advisor:Ionis:Active (exists now) ; Advisor:Astra Zeneca:Active (exists now) ; Speaker:Pfizer:Active (exists now) ; Speaker:Novo Nordisk:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Bridging the Gaps in the Management of Cardiac Amyloidosis - Where are we in 2024?

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

You have to be authorized to contact abstract author. Please, Login
Not Available